Catalyst Wire Dossier Catalyst Wire Dossier

Cedazuridine

Cedazuridine · Astex Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Cedazuridine, covering 2020-10-19 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]

See pricing